Innovation Pharmaceuticals Inc (IPIX)

[Rdunn88]

Karin, 5 or 6 trials might cost them 25 million. There's also other expenses (hiring/travel) that will rise as the company grows. The key is where the PPS will be when further dilution occurs... At 4 PPS, they have a little buffer, but up-listing could be more difficult as a result. That's why Leo is cautious of up-listing, as he's right on-the-border of the minimum requirements. I agree with you, I don't see an up-listing until the PPS is safely above 4, probably after any financial agreement is reached (Aspire or ?) GLTY